Docosahexaenoic Acid and Arachidonic Acid Levels Are Associated with Early Systemic Inflammation in Extremely Preterm

Ann Hellström1, William Hellström2, Gunnel Hellgren1,3

  • 1Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, 40530 Gothenburg, Sweden.

Nutrients
|July 9, 2020
PubMed

Insights

Lower docosahexaenoic acid (DHA) levels at birth are linked to early inflammation in extremely preterm infants. Arachidonic acid (AA) levels showed no significant association with early inflammation.

Area of Science:

  • Neonatal Medicine
  • Nutritional Biochemistry
  • Inflammation Research

Background:

  • Fetal and early postnatal inflammation are linked to increased morbidity in extremely preterm infants.
  • Docosahexaenoic acid (DHA) and arachidonic acid (AA) are critical fatty acids with potential immunomodulatory roles.

Purpose of the Study:

  • To investigate the association between postpartum levels of DHA and AA and early systemic inflammation in extremely preterm infants.
  • To determine if cord blood and early postnatal serum levels of DHA and AA correlate with inflammatory markers.

Main Methods:

  • A cohort of 90 extremely preterm infants was studied.
  • Serum levels of DHA and AA were measured in cord blood, on postnatal day 1, and postnatal day 7.
  • Early systemic inflammation was defined by elevated C-reactive protein (CRP) and/or interleukin-6 (IL-6) within 72 hours of birth, with or without positive blood culture.

Main Results:

  • Infants with early systemic inflammation had significantly lower median serum DHA levels on postnatal day 1 compared to those without inflammation (0.5 mol% lower, P = 0.006).
  • Serum AA levels did not differ significantly between infants with and without signs of inflammation.
  • In cord blood, lower serum levels of both DHA (r = -0.40, P = 0.010) and AA (r = -0.54, P < 0.001) correlated with higher IL-6 levels.

Conclusions:

  • Serum DHA levels at birth are associated with the early postnatal inflammatory response in extremely preterm infants.
  • DHA status may play a role in modulating inflammation in this vulnerable population.
  • Further research is warranted to explore the therapeutic potential of DHA supplementation.